about
Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.Gene promoter methylation is associated with lung function in the elderly: the Normative Aging StudyTissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule.Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease.Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis.Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant miceSystemic inflammation in xenograft recipients precedes activation of coagulationWhat do we mean by the term "inflammation"? A contemporary basic science update for sports medicinemRNA expression of genes involved in inflammation and haemostasis in equine fibroblast-like synoviocytes following exposure to lipopolysaccharide, fibrinogen and thrombin.Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injuryPrevention of lipopolysaccharide-induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils.The role of tissue factor and autophagy in pulmonary vascular remodeling in a rat model for chronic thromboembolic pulmonary hypertensionInhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells.Protease-activated receptor 4: a critical participator in inflammatory response.The characteristics of thrombin in osteoarthritic pathogenesis and treatment.Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation.The procoagulant potential of environmental particles (PM10).Role of the tissue factor pathway in synovial inflammation.Nicotinamide inhibits endotoxin-induced monocyte tissue factor expression.Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres.Molecular challenges and viral diseases.Leukocyte-platelet aggregates and monocyte tissue factor expression in bovines implanted with ventricular assist devices.Expression of tissue factor and forkhead box transcription factor O-1 in a rat model for chronic thromboembolic pulmonary hypertension.The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis
P2860
Q24538771-50F1044F-1B75-4C4C-B004-6E0BE0DEBE74Q28383778-0EC240D7-10FA-4957-916C-C155D71B9E8EQ33741075-F1ED015E-3D8D-4D34-BD95-8ECD54AAA1B6Q33878775-769E016B-B5C8-40F8-BF10-225BC4365E89Q34923078-5BC5D550-A304-43D2-8828-EEAF52292A5FQ35083269-CA114E22-126E-43EF-BDD7-B22A3FAF9E69Q35085219-DCAB58F5-1776-4057-98FD-80B1D91E84CCQ35328558-58F09CF3-0D7B-4B95-B1F3-9C8F01490EF4Q35676119-C0305B4F-1C6E-4D86-9EEF-E69EFF0242CAQ36007691-5A2AEA59-C409-4C1A-9638-C71E32A7C75BQ36371771-76670B59-19F2-4968-8562-E0D13A928ACFQ36945293-3CC14406-7893-4D90-889A-53A973CE0EACQ37286280-FB9D274C-9091-41BE-B9B9-829BAC0187F4Q38239636-DABF2029-C83B-46AA-98CC-7DE7F29038E1Q38260033-EC0237F4-A82D-4C26-B2CA-1EDAE029762CQ39941840-2C14A33A-7766-4985-93BC-9B4218D91C51Q42120267-1DC9C59D-6691-4402-8297-69498BBB1359Q44359271-790160EC-054B-4003-B611-0D3D2E821EECQ44693024-7588C51E-520F-4DE8-B360-EDE5783E1A11Q45871220-3BE53285-E2F5-4039-9E7D-D385486C0C5EQ45872085-F05B9AA3-DA8D-443A-BA0D-5D30F1C9967BQ51065783-13DC33EB-62A1-4EE5-A602-26CDAE570DE9Q51468495-1C19B5E8-D875-44FC-865B-186D048DCE4BQ57673817-9B924850-E7C8-4758-AB40-20FA1F155E33
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tissue factor as a proinflammatory agent
@ast
Tissue factor as a proinflammatory agent
@en
Tissue factor as a proinflammatory agent
@nl
type
label
Tissue factor as a proinflammatory agent
@ast
Tissue factor as a proinflammatory agent
@en
Tissue factor as a proinflammatory agent
@nl
prefLabel
Tissue factor as a proinflammatory agent
@ast
Tissue factor as a proinflammatory agent
@en
Tissue factor as a proinflammatory agent
@nl
P2860
P3181
P356
P1433
P1476
Tissue factor as a proinflammatory agent
@en
P2093
Andrej Tarkowski
Maria I Bokarewa
P2860
P2888
P304
P3181
P356
10.1186/AR405
P407
P577
2002-01-10T00:00:00Z